Literature DB >> 12397730

Regulation of the enteric nervous system in the colon of patients with slow transit constipation.

Ryouichi Tomita1, Katsuhisa Tanjoh, Shigeru Fujisaki, Tarou Ikeda, Masahiro Fukuzawa.   

Abstract

BACKGROUND/AIMS: The cause of impaired motility in patients with slow transit constipation is unknown. To clarify the physiological significance of cholinergic, adrenergic, non-adrenergic non-cholinergic inhibitory nerves in the colon of patients with slow transit constipation, we investigated the enteric nerve responses on lesional and normal bowel segments derived from patients with slow transit constipation and patients who underwent colon resection for colonic cancers.
METHODOLOGY: Twenty preparations were taken from the lesional colon of 6 patients with slow transit constipation (2 men and 4 women, aged 23 to 68 years, with a mean age of 44.0 years). Thirty-six preparations were taken from the normal colon of 12 patients with colonic cancer (6 men and 6 women, aged 40 to 60 years, with a mean age of 52.2 years). A mechanographic technique was used to evaluate in vitro muscle responses to acetylcholine, adrenalin, electrical field stimulation of adrenergic and cholinergic nerves before and after treatment with various autonomic nerve blockers.
RESULTS: The contraction reaction to acetylcholine in the colon with slow transit constipation was significantly weaker than in the normal colon (P < 0.01). The relaxation reaction to adrenalin in the colon with slow transit constipation was stronger than in the normal colon. The colon with slow transit constipation was more strongly innervated by non-adrenergic non-cholinergic inhibitory nerves than the normal colon, significantly (P < 0.05).
CONCLUSIONS: These findings suggest that a decrease of cholinergic nerve and an increase of non-adrenergic non-cholinergic inhibitory nerve play an important role in the impaired motility observed in the colon of patients with slow transit constipation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397730

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Management of chronic constipation in the elderly.

Authors:  Paul F Gallagher; Denis O'Mahony; Eamonn M M Quigley
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

2.  Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation.

Authors:  Ka Ming Yeh; Olle Johansson; Huy Le; Karan Rao; Irit Markus; Dayashan Shevy Perera; David Zachary Lubowski; Denis Warwick King; Li Zhang; Hongzhuan Chen; Lu Liu
Journal:  J Gastroenterol       Date:  2019-08-07       Impact factor: 7.527

Review 3.  The treatment of chronic constipation in elderly people: an update.

Authors:  Wanda Bosshard; Rebecca Dreher; Jean-François Schnegg; Christophe J Büla
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Effect of enterokinetic prucalopride on intestinal motility in fast rats.

Authors:  Hui-Bin Qi; Jin-Yan Luo; Xin Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

5.  Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Dragos Creţoiu; Sanda Maria Creţoiu; Gabriel Becheanu
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

6.  Constipation and diarrhea during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nini G L Callan; Ellen S Mitchell; Margaret M Heitkemper; Nancy F Woods
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

7.  Risk factors for postoperative ileus following orthopedic surgery: the role of chronic constipation.

Authors:  Tae Hee Lee; Joon Seong Lee; Su Jin Hong; Jae Young Jang; Seong Ran Jeon; Dong Won Byun; Won Young Park; Soon Im Kim; Hyung Suk Choi; Jae Chul Lee; Ji Sung Lee
Journal:  J Neurogastroenterol Motil       Date:  2015-01-01       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.